Evaluation of Cardiovascular Risk Factors after Hepatitis C Virus Eradication with Direct-Acting Antivirals in a Cohort of Treatment-Naïve Patients without History of Cardiovascular Disease

Background: Hepatitis C virus (HCV) produces changes at multiple levels in host metabolism, especially in lipid profile and cardio-metabolic risk. It is unclear how HCV eradication by direct-acting antivirals (DAAs) modifies those changes. Objective: To evaluate the impact of DAA treatment on differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Casas-Deza, Diego, Martínez-Sapiña, Ana, Espina, Silvia, Garcia-Rodriguez, Beatriz, Fernandez-Bonilla, Eva M., Sanz-Paris, Alejandro, Gonzalez-Irazabal, Yolanda, Bernal-Monterde, Vanesa, Arbones-Mainar, Jose M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315656/
https://www.ncbi.nlm.nih.gov/pubmed/35887813
http://dx.doi.org/10.3390/jcm11144049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315656/
https://www.ncbi.nlm.nih.gov/pubmed/35887813
http://dx.doi.org/10.3390/jcm11144049

Ejemplares similares